 |
|
Posttreatment Laparotomy for Hodgkin's Disease
Hugo V. Villar, MD;
Stephen E. Jones, MD;
Gary E. Goodman, MD;
Thomas M. Grogan, MD;
Gerald D. Pond, MD;
Stephen L. Wangensteen, MD
Arch Surg. 1983;118(11):1272-1276.
Abstract
| |
• We examined and surgically restaged (using posttreatment laparotomy) 26 patients with stage III and IV Hodgkin's disease treated with combination chemotherapy and in apparent remission to determine the status of their clinical remission. Eleven patients had normal clinical restaging and surgical restaging. Fifteen patients had abnormal clinical restaging, mainly consisting of abnormal lymphangiograms or abdominal CT scans. Ten lymphangiograms were abnormal and could not exclude persistent lymphoma. Two of the 15 patients proved to have Hodgkin's disease involving the para-aortic nodes and the spleen. With a median follow-up of 24 months, two patients had relapses in supradiaphragmatic sites and no patient with a negative laparotomy had a recurrence in abdominal sites. Restaging laparotomy in selected patients with Hodgkin's disease with abnormal lymphangiograms or CT scans may identify additional patients with residual lymphoma who require further therapy and, more importantly, may identify those patients who have no residual disease and, therefore, may be spared additional therapy. Mortality and morbidity were nil.
(Arch Surg 1983;118:1272-1276)
Author Affiliations
From the Departments of Surgery (Drs Villar and Wangensteen), Internal Medicine (Drs Jones and Goodman), Pathology (Dr Grogan), and Radiology (Dr Pond), University of Arizona Health Sciences Center, Tucson.
Footnotes
Accepted for publication May 31, 1983.
Read before the Western Surgical Association Annual Meeting, Crown Center Hotel, Kansas City, Mo, Nov 15, 1982.
Reprint requests to Department of Surgery, University of Arizona Health Sciences Center, Tucson, AZ 85724 (Dr Villar).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
